Sponsor Pipeline

Everest Medicines (Beijing) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07095868 Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in… Selected Types of Solid Tumor Recruiting
Phase 1
NCT07614646 Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With… Squamous Non-Small Cell Lung Cancer sqNSCLC Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Everest Medicines (Beijing) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free